Showing results (921-930 of 1,396) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|April 10, 2018
TMPRSS2-ERG fusions unexpectedly identified in men initially diagnosed with nonprostatic malignanciesPrimo N Lara, Andreas M Heilmann, Julia A Elvin, et al.
JCO Precision Oncology|March 30, 2023
Clinical Targeted Next-Generation Panel Sequencing Reveals MYC Amplification Is a Poor Prognostic Factor in OsteosarcomaAmanda E Marinoff, Liam F Spurr, Christina Fong, et al.
JCO Precision Oncology|May 17, 2023
Diagnosis of Ovarian Carcinoma Homologous Recombination DNA Repair Deficiency From Targeted Gene Capture Oncology AssaysNiklas Krumm, Nithisha S Khasnavis, Marc Radke, et al.
JCO Precision Oncology|August 17, 2022
Clinical Activity of Mitogen-Activated Protein Kinase-Targeted Therapies in Patients With Non-V600 BRAF-Mutant TumorsMatthew Dankner, Yifan Wang, Rouhi Fazelzad, et al.
JCO Precision Oncology|August 24, 2022
Refining Prognosis in Localized Gastrointestinal Stromal Tumor: Clinical Significance of Phosphatase and Tensin Homolog Low Expression and Gene LossXiaolan Feng, Haocheng Li, Joanna Fourquet, et al.
JCO Precision Oncology|May 29, 2020
CDK12-Altered Prostate Cancer: Clinical Features and Therapeutic Outcomes to Standard Systemic Therapies, Poly (ADP-Ribose) Polymerase Inhibitors, and PD-1 InhibitorsEmmanuel S Antonarakis, Pedro Isaacsson Velho, Wei Fu, et al.
JCO Precision Oncology|February 1, 2023
Genomic Complexity as a Biomarker to De-Escalate Adjuvant Imatinib Treatment in High-Risk Gastrointestinal Stromal TumorKjetil Boye, Ludmila Gorunova, Bastian Gunawan, et al.
JCO Precision Oncology|February 1, 2023
Adjuvant Therapy for Renal Cell Carcinoma: End Points, Outcomes, and Risk AssessmentsJoseph J Boyle, John L Pfail, Benjamin J Lichtbroun, et al.
JCO Precision Oncology|February 27, 2023
Optimized Detection of Unknown MET Exon 14 Skipping Mutations in Routine Testing for Patients With Non-Small-Cell Lung CancerRui Sun, Zhizhong Wang, Jiuzhou Zhao, et al.
JCO Precision Oncology|February 27, 2023
Prognostic Significance of Tumor-Infiltrating Lymphocytes Determined Using LinkNet on Colorectal Cancer Pathology ImagesAnran Liu, Xingyu Li, Hongyi Wu, et al.
Pageof 140